Jack Cunningham

Jack is an associate in the Corporate technology and Life sciences team in London. He specialises in advising companies and investors in the technology and life science sectors on venture capital investments, M&A transactions and general corporate matters.

CV

Since 2024 Associate, Taylor Wessing

2022 - 2024 Trainee Solicitor, Taylor Wessing

Carrière

Since 2024 Associate, Taylor Wessing

2022 - 2024 Trainee Solicitor, Taylor Wessing

Formation

2024 Admitted as a lawyer

2022 Master of Laws, BPP Law School (London

2022 Legal Practical Course, BPP Law School (London)

Actualités et publications récentes

View Jack's insights

Cliquer ici pour en savoir plus

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising BeZero Carbon on US$32 million Series C funding

16 janvier 2025

par plusieurs auteurs

Expertise

Services et Groupes

CV

Carrière

Formation

Actualités et publications récentes

Advising BeZero Carbon on US$32 million Series C funding

Jack Cunningham

Expertise

Services et Groupes

CV

Carrière

Formation

Actualités et publications récentes

Advising BeZero Carbon on US$32 million Series C funding

Related news & insights

Sustainability Stories: Notpla

EU Inc. – The 28th Regime: How the European Commission intends to revolutionise the formation of companies

Investing in the German Audit and Tax Advisory Market – Opportunity Amid Regulatory Debate

More Than Share and Asset Deals: Innovative Transaction Structures for MedTech Companies

Advising on Tropic Biosciences' US$105 million Series C financing

German Special Fund for Infrastructure and Climate Neutrality

Taylor Wessing advises TPG Management GmbH, a portfolio company of Alpina Partners, on the acquisition of parameta GmbH

Taylor Wessing advises Podimo ApS on the acquisition of arc.studio GmbH

Taylor Wessing conseille fanxp dans le cadre de l’acquisition d’Alyx

Supply Chain Resilience: The ability to act in uncertain times: using the Hormuz blockade as an example

Autres avocats qui pourraient vous intéresser

Rendez-vous à